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Identity 
Other names: Beta cytoskeletal actin; Beta actin 
HGNC (Hugo): ACTB 
Location: 7p22 
Location (base pair): Position 5340026-5343462 on 
the chromosome 7 genomic sequence. 
Note 
Six actin isoforms are known: two sarcomeric (a-
skeletal and a-cardiac), two smooth muscle actins (a 





Genomic organization of the ACTB gene. 
Description 
Six exons, spans approximately 3.4 kb of genomic 
DNA in the centromere-to-telomere orientation. The 
translation initiation codon ATG is located in exon 2, 
and the stop codon in exon 6. 
Transcription 
mRNA of approximately 1.8 kb. 
Pseudogene 
At least 19 processed, non-expressed, pseudogenes are 





The open reading frame encodes a 374 amino acid 
protein, with an estimated molecular weight of 
approximately 41.7 kDa. 
Expression 





Component (together with cytoplasmic g actin) of the 
cytoskeletal microfilaments. Involved in the transport 
of chromosomes and organelles as well as in cell 
motility. 
Homology 
The ACTB proteins are evolutionary conserved. 
Mammalian cytoplasmic actins (actin g and b) are 
remarkably similar to each other, but differ in at least 
25 residues from the muscle actins. 
Mutations 
Somatic 
ACTB is interrupted by the t(7;12)(p22;q13) detected 
in pericytoma with t(7;12). 
Implicated in 
Disease 
Pericytoma with t(7;12). 
Prognosis 
Benign or low-malignant. 
 












ACTB-GLI1 fusion gene. The breakpoints reported so 
far have been located to introns 1, 2 or 3 within the 
ACTB gene, and to introns 5 or 6 or to exon 7 within 
the GLI1 gene. Reciprocal GLI1-ACTB gene fusions 
have also been detected. The breakpoints have been 
located to introns 5 or 7 within the GLI1 gene, and to 
intron 3 of the ACTB gene. 
 
Representative G-banded partial karyotype of the 
t(7;12)(p22;q13). 
Abnormal protein 
The ACTB-GLI1 fusion protein contains the N-
terminal of ACTB and the C-terminal of GLI1, 
including the DNA-binding zink finger motifs (encoded 
by exons 7-10) and transactivating motifs (exon 12). 
Oncogenesis 
It is suggested that the strong ACTB promoter causes 
an overexpression of GLI1 sequences important for 
transcriptional activation of downstream target genes, 
akin to the oncogenic mechanisms of the COL1A1-
PDGFB fusion gene detected in dermatofibrosarcoma 
protuberans. 
References 
Vandekerckhove J, Weber K. Mammalian cytoplasmic actins 
are the products of at least two genes and differ in primary 
structure in at least 25 identified positions from skeletal muscle 
actins. Proc Natl Acad Sci U S A. 1978 Mar;75(3):1106-10 
Kedes L, Ng SY, Lin CS, Gunning P, Eddy R, Shows T, Leavitt 
J. The human beta-actin multigene family. Trans Assoc Am 
Physicians. 1985;98:42-6 
Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T. 
Molecular structure of the human cytoplasmic beta-actin gene: 
interspecies homology of sequences in the introns. Proc Natl 
Acad Sci U S A. 1985 Sep;82(18):6133-7 
Ng SY, Gunning P, Eddy R, Ponte P, Leavitt J, Shows T, 
Kedes L. Evolution of the functional human beta-actin gene 
and its multi-pseudogene family: conservation of noncoding 
regions and chromosomal dispersion of pseudogenes. Mol Cell 
Biol. 1985 Oct;5(10):2720-32 
Ueyama H, Inazawa J, Nishino H, Ohkubo I, Miwa T. FISH 
localization of human cytoplasmic actin genes ACTB to 7p22 
and ACTG1 to 17q25 and characterization of related 
pseudogenes. Cytogenet Cell Genet. 1996;74(3):221-4 
Simon MP, Pedeutour F, Sirvent N, Grosgeorge J, Minoletti F, 
Coindre JM, Terrier-Lacombe MJ, Mandahl N, Craver RD, Blin 
N, Sozzi G, Turc-Carel C, O'Brien KP, Kedra D, Fransson I, 
Guilbaud C, Dumanski JP. Deregulation of the platelet-derived 
growth factor B-chain gene via fusion with collagen gene 
COL1A1 in dermatofibrosarcoma protuberans and giant-cell 
fibroblastoma. Nat Genet. 1997 Jan;15(1):95-8 
Dahlén A, Fletcher CD, Mertens F, Fletcher JA, Perez-Atayde 
AR, Hicks MJ, Debiec-Rychter M, Sciot R, Wejde J, Wedin R, 
Mandahl N, Panagopoulos I. Activation of the GLI oncogene 
through fusion with the beta-actin gene (ACTB) in a group of 
distinctive pericytic neoplasms: pericytoma with t(7;12). Am J 
Pathol. 2004 May;164(5):1645-53 
Dahlén A, Mertens F, Mandahl N, Panagopoulos I. Molecular 
genetic characterization of the genomic ACTB-GLI fusion in 
pericytoma with t(7;12). Biochem Biophys Res Commun. 2004 
Dec 24;325(4):1318-23 
This article should be referenced as such: 
Dahlén A, Mertens F, Mandahl N, Panagopoulos I. ACTB 
(Actin, beta). Atlas Genet Cytogenet Oncol Haematol. 2005; 
9(2):129-130. 
